Lupin Limited has informed the Exchange regarding a press release dated December 18, 2025, titled "Lupin Signs Exclusive Licensing Agreement with Neopharmed for GastroenterologyBrand Plasil® in the Philippines and Brazil".
Lupin Limited has informed the Exchange regarding a press release dated December 18, 2025, titled "Lupin Signs Exclusive Licensing Agreement with Neopharmed for GastroenterologyBrand Plasil® in the Philippines and Brazil".